An industry for healthy lives

Europe is at the heart of global vaccine research and production. Most of the activities of the major innovative Vaccines Europe members research based-companies are based in the region.

Value of the industry

In the late 18th century, Edward Jenner, an English physician, conducted the first scientific attempt to control smallpox, a life-threatening disease that has ever since been eradicated. Over 200 hundred years later, Europe continues to be at the centre of the global vaccine industry impacting positively the European economy.

Vaccine Europe members, though global in nature and contributing to public health worldwide, undertake most of their R&D and manufacturing operations in Europe. In 2010, 79% of Vaccines Europe members’ production was manufactured in Europe and 58% of the total R&D investment was committed to Europe. Furthermore, Vaccines Europe members play an important role in creating employment making a positive impact on Europe’s economy and society.

The European vaccines industry in figures

Vaccines Europe conducts a biennial survey among its members to map the vaccine industry’s contribution to Europe’s public health and economy. The latest infographic ‘The EU vaccine industry in figures’ can be accessed hereRead more…